CHEMO PHARMA LABORATORIES LTD. - 506365 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ashok SomaniDesignation :- Director CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday, 28/01/2020 For Approving Un-Audited Financial Results For The Quarter Ended December 31, 2019
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2020 ,inter alia, to consider and approve Intimation of meeting of the Board of Directors of the Company to be held on Tuesday, 28/01/2020 ,inter alia, to consider and approve the standalone un-audited financial results for the quarter ended December 31, 2019 Chemo Pharma Laboratories Ltd - 506365 - Closure of Trading Window
This is to inform you that as per the Company''''s Code of Conduct to regulate, monitor and report trading by insiders (''Code''), the Trading Window for dealing in the securities of the Company has been closed for all the Designated Persons and their relatives with effect from January 1, 2020 till 48 (forty eight) hours after the un-audited financial results of the Company for the quarter ended December 31, 2019 become generally available information. Kindly take the above information on your records. CHEMO PHARMA LABORATORIES LTD. - 506365 - Submission Of Revised Un-Audited Financial Results For The Quarter And Half Year Ended 30.09.2019
Submission of Revised Un-Audited Financial Results for the quarter and half year ended 30.09.2019 Chemo Pharma Laboratories Ltd - 506365 - Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended 30.09.2019
Submission of Un-Audited Financial Results for the quarter and half year ended 30.09.2019 Chemo Pharma Laboratories Ltd - 506365 - Outcome of Board Meeting
Submission of Outcome of Board Meeting Chemo Pharma Laboratories Ltd - 506365 - Submission Of Reg 40(9) Of SEBI (LODR), 2015 For The Half Year Ended 30/09/2019
Submission of Reg 40(9) of SEBI (LODR), 2015 for the half year ended 30/09/2019 Chemo Pharma Laboratories Ltd - 506365 - Submission Of Reg 40(9) Of SEBI (LODR), 2015 For The Half Year Ended 30/09/2019
Submission of Reg 40(9) of SEBI (LODR), 2015 for the half year ended 30/09/2019 CHEMO PHARMA LABORATORIES LTD. - 506365 - Submission Of Compliance Certificate Pursuant To The Regulation 7(3) Of Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Quarter And Half Year Ended 30Th September, 2019
Submission of Compliance Certificate Pursuant to the Regulation 7(3) of Securities Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations, 2015 for Quarter and Half Year ended 30th September, 2019 Chemo Pharma Laboratories Ltd - 506365 - Shareholding for the Period Ended September 30, 2019
Chemo Pharma Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here